---
blocking_issues_count: 3
warnings_count: 8
tasklist_ready: false
validation_mode: adversarial
validation_agents: 'opus-architect, haiku-analyzer'
---

## Agreement Table

| Finding ID | Agent A (opus-architect) | Agent B (haiku-analyzer) | Agreement Category |
|---|---|---|---|
| F-01: Timeline/effort contradiction (11 vs 10 sprints) | FOUND (BLOCKING) | FOUND (INFO) | CONFLICT |
| F-02: `interleave_ratio` frontmatter type mismatch | FOUND (INFO) | FOUND (BLOCKING) | CONFLICT |
| F-03: P1.3 traceability gap (missing FR citation) | FOUND (WARNING) | FOUND (BLOCKING, broader scope) | CONFLICT |
| F-04: NFR-001 phase allocation mismatch | FOUND | -- | ONLY_A |
| F-05: P4.1 compound deliverable | FOUND | -- | ONLY_A |
| F-06: P5.5 compound deliverable | FOUND | -- | ONLY_A |
| F-07: P5.6 compound deliverable | FOUND | -- | ONLY_A |
| F-08: P0.3 compound deliverable | -- | FOUND | ONLY_B |
| F-09: P2.5 compound deliverable | -- | FOUND | ONLY_B |
| F-10: P4.3 compound deliverable | -- | FOUND | ONLY_B |
| F-11: Interleave declared value misleading | -- | FOUND (WARNING) | ONLY_B |
| F-12: Phase 3 Sprint-based numbering inconsistency | FOUND (INFO) | -- | ONLY_A |
| F-13: Phase 3 numbered vs bullet list inconsistency | FOUND (INFO) | -- | ONLY_A |

## Consolidated Findings

### BLOCKING

**F-01: Internal timeline/effort contradiction between Executive Summary and Timeline Summary**
- **Agreement**: CONFLICT — Agent A classified BLOCKING, Agent B classified INFO
- **Resolution**: Escalated to **BLOCKING**. This is a factual contradiction in key planning numbers (sprint count, calendar weeks, effort days). The Executive Summary says 11 sprints / ~22 weeks / 39–60 days while the Timeline Summary says 10 sprints / ~20 weeks / 37–57 days. Agent A's per-phase sum verification (3-5 + 4-6 + 9-14 + 10-15 + 7-10 + 4-7 = 37–57) confirms the Timeline Summary is correct. Scheduling metadata must be unambiguous for tasklist generation.
- Location: `roadmap.md:Executive Summary` vs `roadmap.md:Timeline Summary`
- Fix: Update Executive Summary to 10 sprints, ~20 calendar weeks, 37–57 working days.

**F-02: `interleave_ratio` frontmatter type/value mismatch**
- **Agreement**: CONFLICT — Agent A classified INFO ("distinct metrics, no action"), Agent B classified BLOCKING ("wrong type for a ratio field")
- **Resolution**: Escalated to **BLOCKING**. The frontmatter stores `'1:2'` (a string) where downstream tooling expects a numeric value in `[0.1, 1.0]`. Both agents computed the correct value as `1.0`. Even if the string describes a different concept (test cadence), storing a non-numeric value in a field named `interleave_ratio` will cause schema validation failures in automated pipelines.
- Location: `test-strategy.md:frontmatter:interleave_ratio`
- Fix: Change value to `1.0`. Move the "1 test per 2 implementation tasks" cadence description to body text.

**F-03: Incomplete requirement traceability for deliverables**
- **Agreement**: CONFLICT — Agent A found P1.3 only (WARNING), Agent B found P1.3 + P2.4 (BLOCKING, broader scope)
- **Resolution**: Escalated to **BLOCKING**. Agent B identified additional gaps (P2.4 citing only SC-007 with no FR/NFR). The broader finding subsumes Agent A's narrower one. Traceability completeness is a structural requirement for tasklist generation.
- Location: `roadmap.md:P1.3`, `roadmap.md:P2.4`, and potentially other deliverables
- Fix: Add explicit FR/NFR citations to every deliverable (P1.3 → FR-006 partial, P2.4 → relevant FR), or add a requirement-to-deliverable trace table.

### WARNING

**F-04: NFR-001 requirement-to-phase allocation mismatch** (ONLY_A)
- Agent A found NFR-001 allocated to Phase 1 in the roadmap, but the semantic gates it constrains are built in Phase 2. Test-strategy correctly validates it at Milestone B (Phase 2).
- Location: `roadmap.md:Phase 1` requirements vs `test-strategy.md:Milestone B`
- Fix: Move NFR-001 from Phase 1's requirements list to Phase 2's.

**F-05: P4.1 compound deliverable — 3 distinct pipeline stages** (ONLY_A)
- Retrospective-to-Spec Pipeline bundles extraction, conversion, and injection as one deliverable.
- Location: `roadmap.md:P4.1`
- Fix: Split into P4.1a/b/c or accept sc:tasklist auto-decomposition.

**F-06: P5.5 compound deliverable — 4 distinct activities** (ONLY_A)
- Backward Compatibility and Migration bundles regression testing, false-regression confirmation, fallback mode, and migration timeline.
- Location: `roadmap.md:P5.5`
- Fix: Split into P5.5a (regression validation) and P5.5b (fallback + migration).

**F-07: P5.6 compound deliverable — 2 governance domains** (ONLY_A)
- Governance Formalization combines ledger governance and evidence trail audit formalization.
- Location: `roadmap.md:P5.6`
- Fix: Split into P5.6a and P5.6b or accept compound delivery.

**F-08: P0.3 compound deliverable — 5+ distinct outputs** (ONLY_B)
- Architectural Assessment bundles seam mapping, validator classification, architecture evaluation, decision artifact, and conditional branching.
- Location: `roadmap.md:P0.3`
- Fix: Split into seam inventory, validator taxonomy, architecture assessment memo, and go/no-go decision handling.

**F-09: P2.5 compound deliverable — schema + rollout** (ONLY_B)
- Combines YAML schema definition, artifact attachment, and Phase 1 tag extension.
- Location: `roadmap.md:P2.5`
- Fix: Split into schema definition, attachment work, and tooling integration.

**F-10: P4.3 compound deliverable — 6+ testing outputs** (ONLY_B)
- Bundles harness creation, three property suites, mock-test coexistence, non-determinism handling, and defect/environment separation.
- Location: `roadmap.md:P4.3`
- Fix: Break into harness setup, property test suites, coexistence work, and stability-tolerance handling.

**F-11: Declared interleave value misleading** (ONLY_B)
- The `'1:2'` frontmatter value doesn't match the computed `1.0` ratio and could mislead downstream consumers. (Partially overlaps with F-02 but focuses on the misleading semantics rather than the type error.)
- Location: `test-strategy.md:frontmatter`
- Fix: Subsumed by F-02's fix — replace with `1.0`.

### INFO

**F-12: Phase 3 uses Sprint-based numbering instead of P3.x** (ONLY_A)
- Phases 0,1,2,4,5 use P*.* numbering but Phase 3 uses "Sprint 1/2/3" with numbered sub-items.
- Location: `roadmap.md:Phase 3`
- Fix: No action unless sc:tasklist parser expects uniform ID schemes.

**F-13: Phase 3 uses numbered lists while other phases use bullets** (ONLY_A)
- Formatting inconsistency: numbered lists vs bullet lists across phases.
- Location: `roadmap.md:Phase 3`
- Fix: Normalize if sc:tasklist splitter is list-type sensitive.

## Summary

| Severity | Count |
|----------|-------|
| BLOCKING | 3 |
| WARNING | 8 |
| INFO | 2 |

### Agreement Statistics

| Category | Count |
|----------|-------|
| BOTH_AGREE | 0 |
| CONFLICT (escalated) | 3 |
| ONLY_A | 6 |
| ONLY_B | 4 |

### Conflict Resolutions

All 3 conflicts were escalated to BLOCKING per merge protocol:
1. **F-01**: Agent A=BLOCKING, Agent B=INFO → BLOCKING (factual contradiction in planning numbers)
2. **F-02**: Agent A=INFO, Agent B=BLOCKING → BLOCKING (schema type violation)
3. **F-03**: Agent A=WARNING, Agent B=BLOCKING → BLOCKING (broader traceability gap subsumes narrower finding)

### Overall Assessment

**Not ready for tasklist generation.** Three blocking issues must be resolved:
1. Reconcile Executive Summary timeline figures with Timeline Summary (trivial fix)
2. Fix `interleave_ratio` frontmatter to numeric `1.0` (trivial fix)
3. Add explicit FR/NFR traceability to all deliverables, especially P1.3 and P2.4 (moderate effort)

The 8 warnings are predominantly decomposition concerns (6 of 8) where compound deliverables may need splitting for clean tasklist generation. These are non-blocking — sc:tasklist can potentially auto-decompose them — but pre-splitting would improve output quality. The remaining 2 warnings address cross-file consistency (NFR-001 phase allocation) and a misleading frontmatter value subsumed by F-02.

The roadmap is structurally sound: heading hierarchy is valid, milestone DAG is acyclic, interleave ratio computes to 1.0 (healthy distribution), and content is generally parseable. The agents diverged significantly in severity classification (0 findings with matching severity) but converged on identifying the same core issues, indicating thorough but differently-calibrated analysis.
